Loading clinical trials...
Loading clinical trials...
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Conditions
Interventions
Pemafibrate
Placebo
Locations
71
United States
Arizona Retina and Vitreous Consultants
Phoenix, Arizona, United States
Retinal Diagnostic Center
Campbell, California, United States
Macula & Retina Institute
Glendale, California, United States
Atlantis Eye Care
Huntington Beach, California, United States
Loma Linda University Health Care, Department of Ophthalmology
Loma Linda, California, United States
South Coast Retina Center
Long Beach, California, United States
Start Date
January 15, 2018
Primary Completion Date
April 3, 2019
Completion Date
April 3, 2019
Last Updated
September 16, 2020
NCT07449936
NCT07449923
NCT07228559
NCT07351786
NCT05802329
NCT06781255
Lead Sponsor
Jaeb Center for Health Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions